相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis
Anissa A. Widjaja et al.
GASTROENTEROLOGY (2019)
Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation
Jinchunzi Yang et al.
NUTRIENTS (2019)
Molecular pathways of nonalcoholic fatty liver disease development and progression
Fernando Bessone et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis
Xuanming Chen et al.
LIFE SCIENCES (2018)
Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China
Sulan Lin et al.
MEDICINE (2018)
The concept of the CCN protein family revisited: a centralized coordination network
Bernard Perbal
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
Hironori Kitade et al.
NUTRIENTS (2017)
Pathogenesis of nonalcoholic steatohepatitis
Wensheng Liu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
The matricellular protein ccn6 (WISP3) decreases notch1 and suppresses breast cancer initiating cells
Wei Huang et al.
ONCOTARGET (2016)
Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review)
Jun Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Matricellular proteins of the Cyr61/CTGF/NOV (CCN) family and the nervous system
Anna R. Malik et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease
Fang Xie et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
The CCN Family Proteins: Modulators of Bone Development and Novel Targets in Bone-Associated Tumors
Po-Chun Chen et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASH
Lixin Zhu et al.
HEPATOLOGY (2013)
Cyr61/CCN1 affects the integrin-mediated migration of prostate cancer cells (PC-3) in vitro
Patrick Schmitz et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice
Zhaolian Bian et al.
JOURNAL OF LIPID RESEARCH (2013)
Matricellular Protein CCN1 Promotes Regression of Liver Fibrosis through Induction of Cellular Senescence in Hepatic Myofibroblasts
Ki-Hyun Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Plasma NOV/CCN3 Levels Are Closely Associated with Obesity in Patients with Metabolic Disorders
Jihane Pakradouni et al.
PLOS ONE (2013)
Cysteine-rich protein 61 (CCN1) mediates replicative senescence-associated aberrant collagen homeostasis in human skin fibroblasts
Taihao Quan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Cyr61 Induces IL-6 Production by Fibroblast-like Synoviocytes Promoting Th17 Differentiation in Rheumatoid Arthritis
Jinpiao Lin et al.
JOURNAL OF IMMUNOLOGY (2012)
Matricellular Protein CCN1 Activates a Proinflammatory Genetic Program in Murine Macrophages
Tao Bai et al.
JOURNAL OF IMMUNOLOGY (2010)
Susceptibility to Liver Fibrosis in Mice Expressing a Connective Tissue Growth Factor Transgene in Hepatocytes
ZhenYue Tong et al.
HEPATOLOGY (2009)
Functions and mechanisms of action of CCN matricellular proteins
Chih-Chiun Chen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Diagnosis and therapy of nonalcoholic steatohepatitis
Dawn M. Torres et al.
GASTROENTEROLOGY (2008)
Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response
Ping Feng et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Cytotoxicity of TNFα is regulated by integrin-mediated matrix signaling
Chih-Chiun Chen et al.
EMBO JOURNAL (2007)
CCN proteins: multifunctional signalling regulators
B Perbal
LANCET (2004)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
